Whittlesford, United Kingdom

Edward Cleator

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Intervet Inc.. Active years: 2024-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Edward Cleator. Retrieved from https://idiyas.com/inventor/edward-cleator-h943ivff

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Edward Cleator: Innovator in Pharmaceutical Crystals

Introduction

Edward Cleator, an accomplished inventor based in Whittlesford, GB, has made significant contributions in the field of pharmaceutical innovations. With a focus on crystalline forms of complex compounds, Cleator has dedicated his expertise to advancing treatments for various diseases.

Latest Patents

He holds a noteworthy patent for crystalline forms of 1-[(3R,4S)-4-cyanotetrahydropyran-3-yl]-3-[(2-fluoro-6-methoxy-4-pyridyl)amino]pyrazole-4-carboxamide. This patent pertains to the processes for the preparation of these crystalline forms, which have potential applications in treating JAK-mediated diseases, including atopic dermatitis.

Career Highlights

Edward Cleator is currently associated with Intervet Inc., where he has been instrumental in driving innovation and enhancing product development. His focus on pharmaceutical applications showcases his commitment to improving healthcare outcomes through inventive solutions.

Collaborations

Throughout his career, Cleator has collaborated with esteemed colleagues such as Christophe Pierre Alain Chassaing and Xiaoling Jin. These partnerships have enabled him to enhance his research and expand his contributions to the field of medicinal chemistry.

Conclusion

In summary, Edward Cleator is a distinguished inventor whose work in crystalline pharmaceuticals has the potential to impact the treatment of various medical conditions. His dedication to innovation and collaboration continues to make strides in the realm of pharmaceutical research and development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…